Zeto's wireless EEG machine


Zeto and Next Gen Neuro Partner for Remote EEG Monitoring

Providing this end-to-end solution will make EEGs accessible to any healthcare facility in the US

SANTA CLARA, Calif., August 29, 2022 (Newswire.com) – Zeto, Inc., a medical technology company, has announced its partnership with Next Gen Neuro, a continuous and routine EEG monitoring company, to provide remote EEG monitoring services.

Next Gen Neuro (NGN) will serve Zeto customers with real-time EEG monitoring within 30 minutes of a request via the Zeto software. Their registered EEG technologists (R.EEG.T) would then remotely view the EEG and patient video and make annotations. More importantly, they will promptly notify care providers of important clinical events.

“We can help improve patient outcomes by reducing delays in EEG care and allowing for patients to receive care in place, when and where they need it. We are eager to embrace new technologies such as Zeto and develop innovative workflows that will allow us to accomplish these goals while providing the highest quality EEG and cEEG services,” said Leisha Osburn, CEO of NGN. 

“Our new service will make an end-to-end solution for EEG monitoring accessible to any health care facility in the US, from our easy-to-use device to continuous technologist monitoring to timely physician reading, all via our secure cloud, enabling timely, high-quality care for patients. Zeto continues its progress towards serving the growing unmet need of EEG brain monitoring. We are excited to partner with NGN, which provides cutting-edge remote Neurodiagnostic services without boundaries,” said Aswin Gunasekar, CEO of Zeto, Inc.

Zeto also offers remote EEG reading service to its customers and the monitoring service would serve as an ideal complement to customers. Continuous or intermittently monitored EEGs are also eligible for higher reimbursements by payers. 

To learn more on how this new service will work and how it can benefit the patients in hospitals and physician practice settings, read the interview excerpt with Next Gen Neuro Co-founders, CEO Leisha Osburn, and COO Amanda Ritchey.

About Zeto, Inc.

Zeto, Inc. is an award-winning, privately held medical technology company located in Santa Clara, CA, that is focused on transforming the way electroencephalography (EEG) is performed at hospitals and clinics. Zeto’s revolutionary FDA-cleared EEG headset and cloud platform bring the traditional EEG procedure to the 21st century. The company plans to leverage its hardware and software technology to improve noninvasive monitoring of the brain’s electrical activity and achieve better outcomes for neurological conditions such as epilepsy, sleep disorders, autism, stroke and concussion.

To learn more about Zeto’s products including the remote EEG monitoring, please visit: https://zeto-inc.com or email us at info@zetoinc.com.

About Next Gen Neuro

Next Gen Neuro (NGN) is a veteran and women-owned organization inspired and determined to make a difference in the field of Neurodiagnostics. NGN’s goal is to be your partner of choice in providing cutting-edge remote Neurodiagnostic services without boundaries. NGN strives to provide flexible, up-to-date Neurodiagnostic Solutions.

To learn more about Next Gen Neuro services, please visit www.teamngn.com

Source: Zeto and Next Gen Neuro Partner for Remote EEG Monitoring | Newswire

Next Gen Neuro’s Leisha Osburn Knows Remote EEG Monitoring Saves Lives

On August 3rd, Zeto announced the launch of its new remote routine and continuous EEG monitoring services. To provide this service, we partnered with Next Gen Neuro LLC .

We asked Next Gen Neuro Co-founders CEO Leisha Osburn and COO Amanda Ritchey, innovative leaders in the neurodiagnostic industry, about this new service and how it would benefit patients in hospital and clinic settings.

What is your mission and how can your services improve patient outcomes?

Our mission is to be the Next Generation EEG-focused Neurodiagnostic service provider for our partners and their patients, helping them navigate this ever-changing field. We believe we can help improve patient outcomes by reducing delays in EEG care and allowing the opportunity for patients to receive care “in place, when and where they need it.”

We are eager to embrace new technologies and develop innovative workflows that will allow us to accomplish these goals while providing the highest quality EEG and cEEG services.

Why did you decide to start offering remote EEG monitoring?

Leisha Osburn: Around 2007, my team in the Neurophysiology Department at IU Health Methodist hospital became involved in the care of a man in his early 40s who was in status epilepticus. We began EEG monitoring and treatment aimed at stopping the seizures with high doses of medications that placed him in a medically induced coma. The medications had to be kept at just the right levels—enough to suppress the seizures, but not too suppressed — through continuous recording of the EEG. 

At that time, the technology involved in continuously recording long periods of EEG and video data was not very evolved. The concept of having EEG technologists available to continuously monitor the recordings of patients in the ICU like this had never been applied. We would leave the machine on to record at the bedside overnight and the nurses and physicians would check intermittently to see if the brainwaves were still relatively suppressed or if the patient had again begun to have seizures. Then, about halfway through some nights, the storage capacity on the EEG machine would fill up and they would lose the best tool in caring for the patient. 

Unfortunately, this patient passed away after several weeks in the ICU. It motivated all of us to look for better tools and methods for EEG monitoring in the future.

In 2008, I pushed to gain approval for the first ICU continuous EEG program in the country that would have registered EEG technologists (R.EEG.Ts) watching the brainwaves continuously, in real-time. We launched this program successfully and because of the significant impact it had on the care of ICU patients at Methodist hospital, we soon expanded this service to Riley Children’s hospital and Indiana University hospital. It wasn’t long after, that we began providing the service remotely for other IU Health hospitals.

In 2013, I left IU Health and the idea of expanding these remote monitoring services led me to meet our COO, Amanda Ritchey in 2014. Together, with the help of a great team, we built this service successfully for another company, and left at the end of 2019 to create Next Gen Neuro, with the goal of focusing on partnerships with hospitals and other healthcare providers to provide this service with patient care and quality first, above all else.

You recently partnered with Zeto to provide remote EEG monitoring services to Zeto’s customers. Could you describe how this service works?

When Zeto customers need real-time EEG monitoring coverage from Next Gen Neuro they can notify us two ways. If the patient is already set up for the EEG using the Zeto headset, the Zeto customer will click on a service request button in the Zeto software that notifies our monitoring team immediately and monitoring can start in 30 minutes or less. Alternatively, monitoring services can be requested via email at least 30 minutes before the EEG is set to begin. In this case, monitoring will start immediately when the setup is complete.

Then, continuously, in real time, an R.EEG.T remotely views the EEG and patient video, making annotations hourly, and more often as appropriate.  Most importantly, they also rapidly notify care providers of relevant EEG and clinical events, per pre-established, customer directed protocols, as they occur. EEG annotations and logs of all significant events are available immediately at study completion. Technical summary reports inclusive of a descriptive analysis of the EEG are available within 2 hours of study completion.

Will the service actually be available in real time on demand, within 30 minutes, 24/7/365?

Yes, we have R.EEG.Ts scheduled around the clock and multiple layers of redundancy built in to assure this. In addition to the technologists who are pre-scheduled to provide monitoring, we also have shift coordinators available and ready to assist within 5 minutes of add-on requests, monitoring technologists on-call, and a clinical administrator on-call, all of whom are available within 30 minutes.

Will EEG monitoring be done only by registered EEG technologists?

Yes, to be eligible for a position with Next Gen Neuro all candidates must at a minimum, have their R.EEG.T, at least 3 years of ICU and/or epilepsy monitoring unit (EMU) experience (including experience with neonatal, pediatric and adult EEG), and they must commit to obtain their CLTM certification within 2 years of hire if they do not already have this higher-level credential. They must also pass an oral competency and skills assessment as a part of the initial interview process.

Is it possible for healthcare providers to combine their own EEG services with this remote EEG monitoring service? For example, how would this work if one of Zeto’s customers wants to use their own EEG technologists only during certain hours and order remote EEG monitoring from you at times when their EEG specialists are not available.

Yes, in fact this is very common. Many of our customers have their own EEG staff to monitor during the day and only need coverage overnight and on weekends. In the example you gave, we would work with the Zeto customer during the implementation planning process to determine what times, each day, we would receive and hand off EEG patients to and from the facility.

You work with many healthcare providers. What is the most popular use case and what are the biggest benefits of remote EEG services for healthcare providers? 

Generally, there are two common scenarios.

We are contacted by hospitals or physician offices to provide on-site EEG technologists after they have been unsuccessful at this due to the ongoing significant staffing shortages in our field.

Our most popular hospital use case is to provide supplemental/as-needed remote and hybrid on-site/remote coverage of cEEGs and Stat EEGs, primarily overnights and weekends. We believe the biggest benefit of remote EEG services for healthcare providers comes when there are no onsite EEG staff available to set up and perform EEGs and cEEG monitoring. That’s where we provide credentialed, highly qualified technologists, available remotely, in real-time, to perform these services and sound the alarm on any critical events or findings during the EEG.

The ASET Annual Meeting just finished! What are your career recommendations for EEG technologists?

Be a sponge and learn as much as you can. Get involved with ASET and ABRET. Seek formal and informal mentors who can encourage and support your growth in this wonderful profession. There are many areas of focus in Neurodiagnostics, both current and on the horizon. Explore them all and find your passion!

Zeto Now Offers Remote Routine and Continuous EEG Monitoring Service to Its Customers for an Hourly Flat Rate

This service is available in real time upon request with a 30-minute notice 24/7/365.

SANTA CLARA, Calif., August 3, 2022 (Newswire.com) – Zeto, Inc., announced today that it now offers remote routine or continuous electroencephalography (EEG) monitoring services to its customers. At a fixed hourly rate, an accredited monitoring service provides real-time remote video EEG monitoring by registered EEG technologists (R.EEG.T) when such personnel are unavailable on-site. This service is available in real time upon request with a 30-minute notice 24/7/365, at no extra charge during nights, weekends, or holidays. 

Driven by the shortage of in-house monitoring capability, this additional service has become increasingly relevant to hospitals and clinics alike to meet the need for timely, high-quality patient care. Zeto is committed to opening its EEG cloud platform for such services as remote work by medical personnel is gaining adoption.

How it works: When Zeto customers need EEG specialists, they simply click on a service request button in the Zeto software, which notifies the monitoring service immediately, and monitoring starts within 30 minutes. By choice, this service can be requested in advance. In real time, an R.EEG.T remotely views the EEG and patient video, making annotations and notifying care providers when needed.

At an affordable hourly flat rate, providers now have the choice to use this simple and quick remote service. Alternatively, providers can use the Zeto Cloud to have their own EEG technologists monitor and annotate from afar. These options are crucial steps that ensure patient needs can be met with minimal delay while complying with standard practices and documentation requirements.

“We believe this service will be beneficial for everyone, including hospitals that would not be limited by the shortage of EEG professionals and can take care of their patients as fast as needed. Patients can have an EEG recorded, monitored, and reviewed for escalation of critical findings within minutes after the doctor orders it, and registered EEG technologists across the U.S. can apply their skills, even if they are not on-site 24/7/365,” said Florian Strelzyk, Chief Sales Officer at Zeto.

In May, Zeto began offering a remote EEG physician reading service to its customers. This was made possible through a partnership with a physician-led organization dedicated to providing expert, high-quality telemedicine-assisted EEG interpretation to hospitals and outpatient settings, regardless of geographic location.

About Zeto

Zeto, Inc. is an award-winning, privately held medical technology company located in Santa Clara, California, that is focused on transforming the way electroencephalography (EEG) is performed at hospitals and clinics. Zeto’s revolutionary FDA-cleared EEG headset and cloud platform bring the traditional EEG procedure to the 21st century.

To learn more about Zeto’s products, including the remote EEG monitoring, please visit: https://zeto-inc.com/ or email us at info@zetoinc.com.

Source: https://www.newswire.com/news/zeto-now-offers-remote-routine-and-continuous-eeg-monitoring-service-21786666

Zeto Introduces a Remote EEG Reading Service to Its Customers

SANTA CLARA, Calif., May 26, 2022 (GLOBE NEWSWIRE)  — Zeto, Inc., announced today that the company is now offering its customers a remote electroencephalography (EEG) reading service. This was made possible through a partnership with a physician-led organization dedicated to providing expert, high-quality telehealth-assisted EEG interpretation to hospitals and outpatient settings, regardless of geographic location.

There is a growing need for EEGs to be read in a timely manner, especially in healthcare settings when a neurologist is not on call. “Telehealth-driven technologies, such as Zeto’s EEG cloud platform, are great modern tools that allow EEGs to be interpreted quickly and seamlessly. We are delighted to partner with a board-certified EEG reader group, to cover long-term, acute (“stat”) and routine studies, and help improve patient care. The physician readers use innovative technologies, evidence-based protocols, and medical expertise to help hospitals and clinics start, expand, or improve seizure-related care. We are pleased to offer this service to our customers,” said Florian Strelzyk, Chief Sales Officer at Zeto.

As part of the Zeto Reading Service, a team of remote, certified, and specially trained adult and pediatric epileptologists provide real-time or retrospective EEG interpretation in outpatient settings across all 50 states, the District of Columbia, and Puerto Rico.

Current and new customers can request this service by contacting their Zeto account representative. Via this feature, the user can mark a study for interpretation and the platform notifies the customer-approved reader group to safely and securely read that study. Based on urgency and recording length, users are billed a flat professional reader fee and can receive their results within 24 hours. 

About Zeto

Zeto, Inc. is an award-winning, privately held medical technology company located in Santa Clara, CA, that is focused on transforming the way electroencephalography (EEG) is performed at hospitals and clinics. Zeto’s revolutionary FDA-cleared EEG headset and cloud platform bring the traditional EEG procedure to the 21st century. The company plans to leverage its hardware and software technology to improve noninvasive monitoring of the brain’s electrical activity and achieve better outcomes for neurological conditions such as epilepsy, sleep disorders, autism, stroke and concussion.

To learn more about Zeto’s products including the reading service, please visit: www.zetoinc.com or email us at info@zetoinc.com

Source: https://finance.yahoo.com/news/zeto-introduces-remote-eeg-reading-151600029.html

Zeto to Showcase Technology to Make EEG Brain Monitoring More Accessible for New Providers and in Rural and Underserved Communities at 2022 AAN Annual Meeting

Today, Zeto, Inc. announced its participation in the 2022 American Academy of Neurology Annual Meeting, an event for neurologists and neuroscientists, taking place April 2-7, 2022.

The AAN Annual Meeting strives to promote the highest quality patient-centered neurologic care, assert the value of neurology to policymakers and other major stakeholders, and expand the neurology workforce to meet future needs for patient care.

“We are excited to be back in person for the 2022 AAN Annual Meeting. The past two years put a tremendous burden on many private practices and hospitals. In large parts of the U.S., hiring technologists required to record EEGs has been an everyday challenge due to the pandemic. That makes new providers or providers in rural and traditionally underserved communities struggle to offer crucial EEG tests at their own locations.

“For that very reason, Zeto will showcase our FDA-cleared EEG monitoring technology that enables providers to offer brain monitoring even without traditionally trained EEG technologists. Zeto EEG technology helps save valuable time and resources, while not compromising clinical standards. Neurologists can perform an EEG rapidly, even without an EEG technologist on site. At no upfront costs, and for as low as $65 per patient, providers can record full-montage EEG in under five minutes at the same quality as conventional gel EEG. Included in that per-patient fee are an EEG amplifier, consumables, cloud software with storage, video integration, warranty, training, and a powerful report writing tool. Optional EEG reading services further support clinical decision-making. In the past two years, we saw countless examples of how Zeto technology helped support providers to make EEG more available even under the most challenging circumstances,” said Florian Strelzyk, Chief Sales Officer at Zeto.

According to statistics, one in three patients recovering from Covid-19 may experience neurological or psychological effects from their infections, reflecting a growing consensus that the disease can have lasting effects on the brain.

The AAN Annual Meeting is the largest meeting and exhibition in the world to share common scientific and clinical interests in neurology.

About Zeto

Zeto, Inc. is an award-winning privately held medical technology company located in Santa Clara, CA, focused on transforming the way electroencephalography (EEG) is performed at hospitals and clinics. Zeto’s revolutionary FDA-cleared EEG headset and cloud platform bring the traditional EEG procedure to the 21st century. The company plans to leverage its hardware and software technology to improve noninvasive monitoring of the brain’s electrical activity and achieve better outcomes for neurological conditions such as epilepsy, sleep disorders, autism, stroke and concussion.

To learn more about our products, please visit: www.zetoinc.com or email us at info@zetoinc.com


Source: https://www.newswire.com/news/zeto-to-showcase-technology-to-make-eeg-brain-monitoring-more-21675785

Faster & Better EEG Tests with Zeto Health Technology Podcast with Aswin Gunasekar, CEO & Founder, Zeto

For the August installment of the Healthtech Leader of the Month series, we interviewed Aswin Gunasekar, founder and CEO of Zeto. Zeto is a device-driven platform for acquiring, accessing, and interpreting electroencephalograms (EEGs). An EEG is a test used to evaluate electrical activity in the brain.

Zeto Offers a Seamless EEG Experience

Zeto is the first true dry electrode EEG system cleared by the FDA for clinical use. Founder and CEO Aswin Gunasekar breaks down the inefficiencies of traditional EEG.  “If you look at it, the value chain from acquiring the EEG, accessing the data, interpreting the info, and then diagnosing; all these steps were broken,” he says. “The elaborate set up process makes EEG inaccessible. If you need a trained operator, who needs to go through a 10-month certification program just to do this procedure, that’s an instant bottleneck.”
Clinical EEG is arduous: a trained EEG technologist must measure for exact electrode locations, abrade the skin, apply conductive paste, and glue each electrode to the scalp before recording the electrical activity. EEGs are used to diagnose conditions such as brain tumors, inflammation of the brain, seizure disorders including epilepsy, and more.
Zeto’s first product is a wireless, adjustable headset that allows for EEG acquisition with no skin prep or cleanup. Physicians receive live remote viewing of video EEG through the cloud. Zeto’s integrated platform also offers data management and analysis tools for a seamless experience of acquiring EEG, enabling physicians to deliver better neurological care to patients.

Three Lessons Learned

When Aswin Gunasekar worked as an electrical engineer at AMD, designing semiconductor chips, he learned to ask himself: how does the piece that you’re working on fit into the bigger puzzle? “I did a lot of statistical analysis on yield of chips,” he says. “You can get lost in the weeds, or you can put the pieces together and say ‘you can design for this.’”
In the capstone class for his MBA at UT Austin, Aswin formed a team that was eager to solve a pressing issue in healthcare. “My cousin’s story came up. My cousin grew up with epilepsy in the 90s. It took a big toll on his mental and social development, because he was being overdosed on anti-epileptic drugs,” Aswin says. “The drugs are very coarse in nature; they’re not that fine-tuned. His development could have been much better had better tools and care existed back then. We started digging deeper and discovered that EEG is the gold standard for diagnosing conditions like seizures and epilepsy. We instantly knew that it shouldn’t be done the way it’s being done right now, by gluing wires onto the scalp.”
Aswin and the team began developing a headset with soft tip electrodes. “For us, conceptually, I knew there was nothing in science that limited us from doing this. But I knew it would be a journey of constant iterative learning,” he says. Here are a few things Aswin has learned on the way.

Lesson #1: Protect your psychology as a leader.

“Your psychology as a leader is 75% of the ball game. It’s about managing your state, not just about positive thinking. If you are locked in on something that you absolutely need to get done, from a destination standpoint, from a vision standpoint, you will find a way. Never go easy on that,” Aswin says. He recalls how difficult it was as a first-time entrepreneur to find Zeto’s first supporters.
In 2016, Aswin pitched at a Shark Tank competition organized by the Epilepsy Foundation of America, demonstrating Zeto’s prototype on the judges. They won both the People’s Choice and Judge’s Choice awards, raising their first check and confirming that they were on the right path. Aswin cites how important that first inflection point was in boosting their confidence. “Without clarity of thought and managing your psychology as a leader, you’re not going to be able to inspire people to join forces with you,” he says.

Lesson #2: Think big but execute small.

“Think big but execute in small steps. It’s also self-motivating; you can celebrate those wins and it motivates the people in your team and it’ll motivate more people to come in and join you,” Aswin says. One of his big-picture goals for Zeto is to bring more companies onto their platform and to give valuable information about the brain to clinical providers and neuroscientists. He plans to get there with the same strategy he’s used from the start: take it step by step.
“Plan and execute. Take out the biggest risk first. Always keep chopping away at that,” he says. “It doesn’t matter whether it’s a technical issue, a commercial traction issue, it’s the same thing: take that problem, break it down into pieces, understand the biggest risk within that bucket, and knock that down first. And then move to the next one.”

Lesson #3: Hire for grit.

“The ground floor, especially the first hundred people in a company, are so important to how the company lives, breathes, and develops into an organism of its own,” Aswin says. “I’m personally involved with every little hire; it doesn’t matter whether it’s a consultant, or part-time, or full-time; I’ll be involved with the first three hundred people.” Aswin looks for people who not only have the skillset and experience, but for those who demonstrate the “startup spirit;” the ability to persevere, to get knocked down and get back up. “It’s not just resume. It’s not just their experience and their accomplishments, you also need to hire for grit and tenacity,” he says. “You don’t see that just on the resume. We actively try to unearth that.”

Beyond the Business Books: Final Thoughts

One of the ways that Aswin wants to grow as a CEO is by growing overall as a person. “I’ve always learned the most from unconnected sources. I think I’m past the stage where I just go read business books. Those are good too, but I think the world is a little bit more complex than that,” Aswin says. “If we are taking a product and selling it to a customer, we are selling it to a human being who has their own life going on. How are we presenting our product as they go through their lives? That kind of learning will come from a better understanding of the nuances of the world.”

Zeto’s next goal is to expand its product portfolio and make their cloud infrastructure more capable. “Right now, Zeto is extremely useful for short-term EEG, but brain monitoring is a lot bigger,” Aswin says. “We need to make products that will allow people to be monitored for hours or days on end. There is a real need here, and we’re talking about brain monitoring! Once you give people a better platform, they’re going to do wonderful things with it.”

Listen to Aswin’s episode on the Health Technology Podcast.

Source: https://rosenmaninstitute.org/healthtech-leaders/healthtech-leader-of-the-month-aswin-gunasekar-ceo-zeto/

Wireless EEG for Fast Prep and Easy Use: Q&A with Aswin Gunasekar, CEO of Zeto

Electroencephalography (EEG) devices are incredibly helpful in diagnosing and monitoring certain brain disorders, such as epilepsy and strokes. However, they are not particularly user-friendly or convenient, with specialized technicians performing time consuming procedures, such as skin preparation, to get patients ready to undergo the procedure. A combination of messy gels and wires also makes for an uncomfortable and inconvenient experience for patients.

Woman wearing Zeto's wireless EEG machine

In response, Zeto Inc., a medtech startup based in California, has developed a new EEG device that sits on the head like a bicycle helmet. The headset does not require gels or pastes to function, and can transmit data wirelessly. The company claims that the new system can reduce setup times from the current 20-30 minutes required with conventional systems to just five minutes, potentially making the Zeto device very useful in emergency situations. Best of all, the headset does not require a specialized technician for setup and use, and so could be quickly applied by nursing staff or other clinicians.    

The device is currently being trialed at Methodist Le Bonheur Healthcare in Memphis, Tennessee, to see how it compares with traditional EEG equipment in a clinical setting.

Here’s a video intro from Zeto Inc. about the company’s technology:

Medgadget had the opportunity to talk to Aswin Gunasekar, Founder and CEO of Zeto Inc., about the technology:

Conn Hastings, MedgadgetPlease give us an overview of conventional EEG devices, and their limitations.

Aswin Gunasekar, Zeto: Conventional EEG devices require a trained EEG technologist to measure the head, mark electrode locations, abrade the skin, and apply paste and electrodes to the scalp, eventually tethering the patient to a box with wires. This procedure consumes time, requires technologists who need to be perpetually on-call, and puts the patients through a needlessly poor experience. The scarcity of EEG technologists makes the problem worse, and even unfeasible in many hospitals, emergency rooms and other outpatient settings. Essential features such as easy data access and remote interpretation remain unavailable for conventional EEG devices.

Zeto's wireless EEG machine

MedgadgetHow does the new device developed by Zeto compare with conventional EEG in terms of speed and ease of use?

Aswin Gunasekar: Zeto’s Instant EEG Platform (zEEG) provides the first FDA cleared zero-prep, wireless, dry electrode headset that can be used to perform a routine or urgent EEG anywhere without the need for a trained expert. The device is quickly and easily placed on the patient’s head much like a bicycle helmet. Data are streamed via a HIPAA compliant cloud platform that provides live viewing, tools for analysis and optional remote interpretation by neurologists. Time to interpretable EEG is typically 5 minutes with built-in positioning as per the international 10-20 EEG system. Total overhead time for set up and patient clean up with the Zeto headset is typically under 10 mins compared to over 45 minutes with conventional EEG.

MedgadgetGiven the current pandemic, how does the Zeto EEG device help with reducing the potential for viral transmission?

Aswin Gunasekar: Due to the convenience and simplicity of Zeto’s EEG technology, PPE and exposure time for healthcare workers is reduced significantly. The headset utilizes single-use, disposable electrodes and an optional liner which reduces contact between the patient and the reusable headset, reducing the risk of contamination. Zeto has not yet performed studies on reducing viral transmission. However, the faster setup, zero patient clean up and the ability to monitor the recording with live video from outside the room helps reduce exposure of staff. 

MedgadgetWhat types of mobile devices are compatible with the Zeto EEG device? Is the mobile interface easy to use?

Aswin Gunasekar: Most laptops, desktops and mobile devices capable of running the latest version of Google Chrome web-browser are compatible with the Zeto EEG device. Users of zEEG devices are provided with web-based access, an EEG study manager, video review, annotation features, time-frequency analysis, report generator, analytics and automated software upgrades. The mobile interface – as well as that of laptops and desktops – is simple, intuitive and easy-to-navigate.

MedgadgetHow are data transmitted and how do you deal with data security?

Aswin Gunasekar: The security of our customer and patient data is of foremost importance to us. Zeto employs Design, Technical, Physical and Compliance controls to ensure the integrity and availability of the data on our platform. Data are transmitted with industry-standard AES encryption on the move and at rest. Data access is controlled through strict authentication and authorization protocols. The Zeto Cloud Platform is compliant to HIPAA rules, FDA 21CFR820 cybersecurity requirements and NIST SP800-53 Cybersecurity controls, and all Zeto personnel are HIPAA trained. 

MedgadgetPlease give us an overview of the current trial of the device at Methodist Le Bonheur Healthcare in Memphis, Tennessee.

Aswin Gunasekar: Methodist Le Bonheur Healthcare is the very first hospital system globally to participate in the ongoing trial that compares the capabilities and benefits of Zeto’s EEG technology against traditional EEGs. The trial conducts 3 phases, namely 1) Inpatient (ICU) EEG for detecting subclinical seizures and status epilepticus, 2) Outpatient EEG with trained EEG technologists and 3) Outpatient EEG with staff who are not certified technologists. The current trial could result in a clinical breakthrough that transforms how we approach EEGs in the future. 

Source – https://www.medgadget.com/2020/09/wireless-eeg-for-reduced-prep-time-and-non-specialist-use-interview-with-aswin-gunasekar-ceo-of-zeto.html

HealthTech Arkansas names five early-stage companies for latest cohort

HealthTech Arkansas announced the five early-stage companies selected for the 2020 HealthTech Arkansas healthcare accelerator.

The accelerator is supported by 11 Arkansas healthcare organizations, including Arkansas Children’s Hospital, Arkansas Heart Hospital, Arkansas Urology, Baptist Health, CHI St. Vincent, Conway Regional Health System, Mercy, OrthoArkansas, St. Bernards Healthcare, University of Arkansas for Medical Sciences, and Washington Regional Medical Center.

Representatives from each of the 11 healthcare providers interviewed applicants and selected companies with technologies that have the potential to advance innovation at their respective organizations. The five companies were selected from hundreds of applicants across 14 different countries and are headquartered across the country in California, Utah, and Pennsylvania.

The five companies are:

Astarte Medical, Yardly, Pa.
Astarte Medical is a precision nutrition company using software and predictive analytics to improve outcomes during the first 1,000 days of life. With an initial focus on preterm infants, Astarte Medical supports feeding protocols, practice, and decision-making in the neonatal ICU with a suite of digital tools and diagnostics designed to standardize feeding, optimize nutrition and quantify gut health.

nView Medical, Salt Lake City, Utah
The nView_s1 is an imaging system that provides instant 3D images in the OR with minimal radiation. Like a C-arm, the nView_s1 images from a stationary single position. Unlike a C-arm, novel AI reconstruction techniques allow it to provide 3D images.

Raydiant Oximetry, San Ramon, Calif.
Raydiant Oximetry has developed a non-invasive fetal pulse oximeter to directly monitor a fetus’s blood oxygen saturation during labor and delivery and provide the key missing vital sign that clinicians need to more accurately assess the baby’s health during childbirth.

Vena Vitals, Irvine, Calif.
Vena Vitals, Inc. is re-innovating the way blood pressure is monitored by using soft stretchable sensors that can conform to the body and accurately measure arterial pulse. Their technology provides the benefits of continuous, beat-to-beat blood pressure measurements, but in a non-invasive way.

Zeto, Santa Clara, Calif.
Zeto has taken a significant step towards simplifying EEG. The Zeto product is the first and only dry electrode EEG headset and cloud platform cleared by the FDA for clinical use.

“Our provider partners around the state are excited to introduce the new cohort companies to their teams and launch pilot programs that can make a difference in patient care,” said Jeff Stinson, director of HealthTech Arkansas. “We’ve expanded the applicant pool and the number of providers in our coalition in each of the three years at HealthTech Arkansas. The guaranteed pilot projects and clinical studies from our providers around the state are what differentiates us from any other program in the country.”

The cohort will participate in a program that provides them the opportunity to pilot solutions specifically identified by the 11 participating Arkansas healthcare groups as areas of opportunity within their organizations.

HealthTech Arkansas is a third-year accelerator program focused exclusively on provider engagement with early-stage companies and works with both Arkansas-based and out-of-state companies. The Arkansas Economic Development Commission awarded a grant to HealthTech Arkansas through a program designed to increase acceleration activities in targeted industries in the state.

Source – https://talkbusiness.net/2020/09/healthtech-arkansas-names-five-early-stage-companies-for-latest-cohort/

New study tests “first-of-its-kind” EEG device

A press release states that EEG (electroencephalogram) tests are conducted to detect problems in the brain that may be associated with certain brain disorders such as seizures, tumors or strokes. A typical EEG test consists of multiple electrodes attached to a patient’s scalp with adhesive. Those electrodes have several wires connected to an amplifier which further connects to a computer that measures and records the results.

The setup and removal of a typical EEG test takes between 20–30 minutes. This new US Food and Drug Administration (FDA)-approved product, called zEEG from Zeto, (headquartered in Santa Clara, USA), can be set up in less than five minutes; which offers a more efficient and comfortable experience for the patient.

The patient wears equipment that looks like a high-tech bicycle helmet. The electrodes do not need to be glued to the patient’s scalp, do not leave any residue on the patient and there are no wires connected to an amplifier or computer.

An EEG technician at Methodist University can now be more productive and perform more EEGs in a day. The EEG and video recording are uploaded to the cloud where a specialist can read them at their own convenience.

The ZETO Instant EEG has been beneficial in the midst of the unprecedented COVID-19 pandemic. Due to the convenience of this EEG technology, personal protective equipment (PPE) and exposure time for healthcare workers is reduced significantly. Fast setup and clean up decrease the exposure times for nurses and other care providers. The ZETO Instant EEG uses single-use electrodes which also reduces the risk of contamination.

Source – https://neuronewsinternational.com/new-eeg-device/